Metagenomic study of pulmonary microbiome in patients with airway stenosis

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100054467

Enrollment

Unknown

Registered

2021-12-18

Start date

2021-12-20

Completion date

Unknown

Last updated

2022-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

airway stenosis

Interventions

Tracheal intubation-induced airway stenosis group:None

Tuberculosis infection-induced airway stenosis group:None

Malignant tumor-induced airway stenosis group:None

Eligibility

Sex/Gender

All

Age

18 Years to 55 Years

Inclusion criteria

Inclusion criteria: 1. Previous or current diagnosis of primary/secondary airway malignancy, or tracheal/bronchial tuberculosis, or a history of endotracheal intubation; 2. The diagnosis of primary/secondary malignant tumor invading the airway, or Mycobacterium tuberculosis infection, or airway stenosis caused by endotracheal intubation was confirmed by bronchoscopy.

Exclusion criteria

Exclusion criteria: 1. Those with contraindications to bronchoscopy; 2. Active pulmonary tuberculosis; 3. History of lower respiratory tract infection or antibiotic treatment within the past 1 month.

Design outcomes

Primary

Measure	Time frame
pulmonary microbiome;	—

Countries

China

Contacts

Public ContactFan Zeqin

Affiliated Hospital of Yunnan University

fzq687387@163.com+86 14787482307

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026